Literature DB >> 9622221

Heparin cofactor II: a new marker for pre-eclampsia.

J Bellart1, R Gilabert, L Cabero, J Fontcuberta, J Monasterio, R M Miralles.   

Abstract

The plasma levels of heparin cofactor II were determined in pregnant women who were either normotensive, or had essential hypertension, gestational hypertension or pre-eclampsia during the third trimester and 72 h after delivery. Heparin cofactor II levels in the pre-eclampsia group were depressed. The clinical relevance of this finding is the potential utility of heparin cofactor II plasma levels in the differential diagnostic between non-proteinuric hypertension and pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622221

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  3 in total

1.  Heparin cofactor II inhibits arterial thrombosis after endothelial injury.

Authors:  Li He; Cristina P Vicente; Randal J Westrick; Daniel T Eitzman; Douglas M Tollefsen
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II.

Authors:  Tusar K Giri; Douglas M Tollefsen
Journal:  Blood       Date:  2005-12-08       Impact factor: 22.113

3.  Strain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient mice.

Authors:  Ken-ichi Aihara; Hiroyuki Azuma; Masashi Akaike; Yasumasa Ikeda; Masataka Sata; Nobuyuki Takamori; Shusuke Yagi; Takashi Iwase; Yuka Sumitomo; Hirotaka Kawano; Takashi Yamada; Toru Fukuda; Takahiro Matsumoto; Keisuke Sekine; Takashi Sato; Yuko Nakamichi; Yoko Yamamoto; Kimihiro Yoshimura; Tomoyuki Watanabe; Takashi Nakamura; Akimasa Oomizu; Minoru Tsukada; Hideki Hayashi; Toshiki Sudo; Shigeaki Kato; Toshio Matsumoto
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.